M L Agrawal|S P Mukherjee|S S Prasad - JoVE Visualize

Showing results (61-70 of 68) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 68 results.

Neuroscience|April 17, 2002

Gene expression patterns during enhanced periods of visual cortex plasticityS S Prasad, L Z Kojic, P Li, et al.

Neuroscience|October 22, 2003

Relationship between expression of multiple drug resistance proteins and p53 tumor suppressor gene proteins in human brain astrocytesM Marroni, M L Agrawal, K Kight, et al.

Journal of Pharmaceutical and Biomedical Analysis|January 8, 2008

Development and validation of GC-MS method for the determination of methyl methanesulfonate and ethyl methanesulfonate in imatinib mesylateK Ramakrishna, N V V S S Raman, K M V Narayana Rao, et al.

Journal of Cancer Research and Therapeutics|February 22, 2024

A Multi-centric retrospective study into the epidemiological distribution of breast cancer patients in IndiaVijay Anand Reddy, Ramesh Sarin, Dipanjan Panda, et al.

Asian Pacific Journal of Cancer Prevention : APJCP|October 31, 2015

Correlation between EGFR Gene Mutations and Lung Cancer: a Hospital-Based StudyKavitha Matam, Iravathy Goud, Adi Maha Lakshmi M, et al.

Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|March 27, 2015

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemiaM B Agarwal, Hemant Malhotra, Prantar Chakrabarti, et al.

Blood|May 17, 2014

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myelomaJesús San-Miguel, Joan Bladé, Ofer Shpilberg, et al.

Lancet (London, England)|June 14, 2026

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trialMeletios A Dimopoulos, Fredrik Schjesvold, Chengcheng Fu, et al.

Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 68 results.

Neuroscience|April 17, 2002

Gene expression patterns during enhanced periods of visual cortex plasticityS S Prasad, L Z Kojic, P Li, et al.

Neuroscience|October 22, 2003

Relationship between expression of multiple drug resistance proteins and p53 tumor suppressor gene proteins in human brain astrocytesM Marroni, M L Agrawal, K Kight, et al.

Journal of Pharmaceutical and Biomedical Analysis|January 8, 2008

Development and validation of GC-MS method for the determination of methyl methanesulfonate and ethyl methanesulfonate in imatinib mesylateK Ramakrishna, N V V S S Raman, K M V Narayana Rao, et al.

Journal of Cancer Research and Therapeutics|February 22, 2024

A Multi-centric retrospective study into the epidemiological distribution of breast cancer patients in IndiaVijay Anand Reddy, Ramesh Sarin, Dipanjan Panda, et al.

Asian Pacific Journal of Cancer Prevention : APJCP|October 31, 2015

Correlation between EGFR Gene Mutations and Lung Cancer: a Hospital-Based StudyKavitha Matam, Iravathy Goud, Adi Maha Lakshmi M, et al.

Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|March 27, 2015

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemiaM B Agarwal, Hemant Malhotra, Prantar Chakrabarti, et al.

Blood|May 17, 2014

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myelomaJesús San-Miguel, Joan Bladé, Ofer Shpilberg, et al.

Lancet (London, England)|June 14, 2026

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trialMeletios A Dimopoulos, Fredrik Schjesvold, Chengcheng Fu, et al.

Pageof 7